12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpe
|
ENSMUSG00000052435.6 | CCAAT/enhancer binding protein (C/EBP), epsilon |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cebpe | mm10_v2_chr14_-_54712139_54712174 | 0.03 | 9.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_+_41105359 | 5.78 |
ENSMUST00000047286.6
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr16_+_32756336 | 5.39 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr7_+_49975228 | 4.44 |
ENSMUST00000107603.1
|
Nell1
|
NEL-like 1 |
chr5_-_86906937 | 4.11 |
ENSMUST00000031181.9
ENSMUST00000113333.1 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr4_+_106733883 | 3.95 |
ENSMUST00000047620.2
|
Fam151a
|
family with sequence simliarity 151, member A |
chrX_+_164139321 | 3.62 |
ENSMUST00000112271.3
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr1_-_158814469 | 3.44 |
ENSMUST00000161589.2
|
Pappa2
|
pappalysin 2 |
chr4_+_110397764 | 3.22 |
ENSMUST00000097920.2
ENSMUST00000080744.6 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr11_-_31824518 | 3.09 |
ENSMUST00000134944.1
|
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr6_-_78468863 | 3.04 |
ENSMUST00000032089.2
|
Reg3g
|
regenerating islet-derived 3 gamma |
chr7_-_66427469 | 2.97 |
ENSMUST00000015278.7
|
Aldh1a3
|
aldehyde dehydrogenase family 1, subfamily A3 |
chr9_-_45204083 | 2.96 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr8_-_72212837 | 2.92 |
ENSMUST00000098630.3
|
Cib3
|
calcium and integrin binding family member 3 |
chr4_+_110397661 | 2.80 |
ENSMUST00000106589.2
ENSMUST00000106587.2 ENSMUST00000106591.1 ENSMUST00000106592.1 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr11_-_58529984 | 2.56 |
ENSMUST00000062869.2
|
Olfr330
|
olfactory receptor 330 |
chrX_+_107816477 | 2.55 |
ENSMUST00000143975.1
ENSMUST00000144695.1 ENSMUST00000167154.1 |
Fam46d
|
family with sequence similarity 46, member D |
chr7_+_51880312 | 2.35 |
ENSMUST00000145049.1
|
Gas2
|
growth arrest specific 2 |
chr3_+_106113229 | 2.34 |
ENSMUST00000079132.5
ENSMUST00000139086.1 |
Chia
|
chitinase, acidic |
chr4_+_82065855 | 2.26 |
ENSMUST00000151038.1
|
Gm5860
|
predicted gene 5860 |
chr17_+_21691860 | 2.17 |
ENSMUST00000072133.4
|
Gm10226
|
predicted gene 10226 |
chr16_+_23290464 | 2.09 |
ENSMUST00000115335.1
|
St6gal1
|
beta galactoside alpha 2,6 sialyltransferase 1 |
chr14_-_13914478 | 2.04 |
ENSMUST00000144914.1
|
Gm281
|
predicted gene 281 |
chr10_-_127041513 | 2.03 |
ENSMUST00000116231.2
|
Mettl21b
|
methyltransferase like 21B |
chr12_-_80132802 | 1.90 |
ENSMUST00000180643.1
|
2310015A10Rik
|
RIKEN cDNA 2310015A10 gene |
chrX_+_103321398 | 1.87 |
ENSMUST00000033689.2
|
Cdx4
|
caudal type homeobox 4 |
chr6_+_5390387 | 1.82 |
ENSMUST00000183358.1
|
Asb4
|
ankyrin repeat and SOCS box-containing 4 |
chr5_-_87140318 | 1.80 |
ENSMUST00000067790.6
ENSMUST00000113327.1 |
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr14_+_75242287 | 1.76 |
ENSMUST00000022576.8
|
Cpb2
|
carboxypeptidase B2 (plasma) |
chr1_+_16688405 | 1.74 |
ENSMUST00000026881.4
|
Ly96
|
lymphocyte antigen 96 |
chr17_+_6673610 | 1.72 |
ENSMUST00000097430.2
|
Sytl3
|
synaptotagmin-like 3 |
chr11_+_61022560 | 1.69 |
ENSMUST00000089184.4
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr6_-_5496296 | 1.66 |
ENSMUST00000019721.4
|
Pdk4
|
pyruvate dehydrogenase kinase, isoenzyme 4 |
chrX_-_74645635 | 1.65 |
ENSMUST00000114119.1
|
Gm5640
|
predicted gene 5640 |
chr16_-_22161450 | 1.63 |
ENSMUST00000115379.1
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr11_-_58502554 | 1.62 |
ENSMUST00000170501.2
ENSMUST00000081743.2 |
Olfr331
|
olfactory receptor 331 |
chrX_-_162565514 | 1.62 |
ENSMUST00000154424.1
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr19_+_26623419 | 1.62 |
ENSMUST00000176584.1
|
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr3_+_96268654 | 1.60 |
ENSMUST00000098843.2
|
Hist2h3b
|
histone cluster 2, H3b |
chr9_-_105828085 | 1.54 |
ENSMUST00000166431.2
ENSMUST00000098441.3 |
Col6a6
|
collagen, type VI, alpha 6 |
chr3_+_60031754 | 1.47 |
ENSMUST00000029325.3
|
Aadac
|
arylacetamide deacetylase (esterase) |
chr7_+_139214661 | 1.45 |
ENSMUST00000135509.1
|
Lrrc27
|
leucine rich repeat containing 27 |
chr4_+_82065924 | 1.44 |
ENSMUST00000161588.1
|
Gm5860
|
predicted gene 5860 |
chr15_+_87625214 | 1.42 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chr1_-_156036473 | 1.41 |
ENSMUST00000097527.3
ENSMUST00000027738.7 |
Tor1aip1
|
torsin A interacting protein 1 |
chr2_-_164356507 | 1.39 |
ENSMUST00000109367.3
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr5_-_6876523 | 1.37 |
ENSMUST00000164784.1
|
Zfp804b
|
zinc finger protein 804B |
chr13_-_18382041 | 1.37 |
ENSMUST00000139064.2
ENSMUST00000175703.2 |
Pou6f2
|
POU domain, class 6, transcription factor 2 |
chr9_-_119341390 | 1.34 |
ENSMUST00000139870.1
|
Myd88
|
myeloid differentiation primary response gene 88 |
chr11_-_3931960 | 1.33 |
ENSMUST00000109990.1
ENSMUST00000020710.4 ENSMUST00000109989.3 ENSMUST00000109991.1 ENSMUST00000109993.2 |
Tcn2
|
transcobalamin 2 |
chr15_+_31224371 | 1.32 |
ENSMUST00000044524.9
|
Dap
|
death-associated protein |
chr14_+_32991379 | 1.31 |
ENSMUST00000038956.4
|
Lrrc18
|
leucine rich repeat containing 18 |
chr5_+_8056527 | 1.31 |
ENSMUST00000148633.1
|
Sri
|
sorcin |
chr6_-_78378851 | 1.26 |
ENSMUST00000089667.1
ENSMUST00000167492.1 |
Reg3d
|
regenerating islet-derived 3 delta |
chr10_+_82985473 | 1.26 |
ENSMUST00000040110.7
|
Chst11
|
carbohydrate sulfotransferase 11 |
chr6_+_123262107 | 1.24 |
ENSMUST00000032240.2
|
Clec4d
|
C-type lectin domain family 4, member d |
chr7_-_46715676 | 1.22 |
ENSMUST00000006956.7
|
Saa3
|
serum amyloid A 3 |
chr4_+_58285930 | 1.22 |
ENSMUST00000081919.5
ENSMUST00000102893.3 ENSMUST00000084578.5 ENSMUST00000098057.3 ENSMUST00000179951.1 ENSMUST00000098059.3 ENSMUST00000177951.1 |
Musk
|
muscle, skeletal, receptor tyrosine kinase |
chr7_-_46099752 | 1.22 |
ENSMUST00000180081.1
|
Kcnj11
|
potassium inwardly rectifying channel, subfamily J, member 11 |
chr7_-_25477607 | 1.22 |
ENSMUST00000098669.1
ENSMUST00000098668.1 ENSMUST00000098666.2 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr5_+_90518932 | 1.21 |
ENSMUST00000113179.2
ENSMUST00000128740.1 |
Afm
|
afamin |
chr19_-_32061438 | 1.21 |
ENSMUST00000096119.4
|
Asah2
|
N-acylsphingosine amidohydrolase 2 |
chr8_+_35375719 | 1.21 |
ENSMUST00000070481.6
|
Ppp1r3b
|
protein phosphatase 1, regulatory (inhibitor) subunit 3B |
chr1_+_88070765 | 1.21 |
ENSMUST00000073772.4
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr3_+_106482427 | 1.20 |
ENSMUST00000029508.4
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr1_+_40225051 | 1.20 |
ENSMUST00000027241.4
|
Il1r1
|
interleukin 1 receptor, type I |
chr15_-_34495180 | 1.19 |
ENSMUST00000022946.5
|
Hrsp12
|
heat-responsive protein 12 |
chr17_+_21690766 | 1.19 |
ENSMUST00000097384.1
|
Gm10509
|
predicted gene 10509 |
chr2_+_86041317 | 1.18 |
ENSMUST00000111589.1
|
Olfr1033
|
olfactory receptor 1033 |
chr2_+_62664279 | 1.16 |
ENSMUST00000028257.2
|
Gca
|
grancalcin |
chr12_+_69790288 | 1.14 |
ENSMUST00000021378.3
|
4930512B01Rik
|
RIKEN cDNA 4930512B01 gene |
chr4_-_108118504 | 1.14 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr13_-_92030897 | 1.12 |
ENSMUST00000149630.1
|
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr7_+_90426312 | 1.12 |
ENSMUST00000061391.7
|
Ccdc89
|
coiled-coil domain containing 89 |
chr10_+_69219357 | 1.11 |
ENSMUST00000172261.1
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr4_+_102421518 | 1.10 |
ENSMUST00000106904.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr7_+_50599180 | 1.10 |
ENSMUST00000119710.2
|
4933405O20Rik
|
RIKEN cDNA 4933405O20 gene |
chr14_+_22019712 | 1.10 |
ENSMUST00000075639.4
ENSMUST00000161249.1 |
1700112E06Rik
|
RIKEN cDNA 1700112E06 gene |
chr10_+_62920648 | 1.09 |
ENSMUST00000144459.1
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chr5_+_81021583 | 1.08 |
ENSMUST00000121707.1
|
Lphn3
|
latrophilin 3 |
chr7_+_19359740 | 1.08 |
ENSMUST00000140836.1
|
Ppp1r13l
|
protein phosphatase 1, regulatory (inhibitor) subunit 13 like |
chr1_+_55052770 | 1.08 |
ENSMUST00000027125.5
ENSMUST00000087617.4 |
Coq10b
|
coenzyme Q10 homolog B (S. cerevisiae) |
chr14_+_51114455 | 1.08 |
ENSMUST00000100645.3
|
Eddm3b
|
epididymal protein 3B |
chr18_+_37421418 | 1.07 |
ENSMUST00000053073.4
|
Pcdhb11
|
protocadherin beta 11 |
chr17_+_21555046 | 1.07 |
ENSMUST00000079242.3
|
Zfp52
|
zinc finger protein 52 |
chr6_+_70726430 | 1.06 |
ENSMUST00000103410.1
|
Igkc
|
immunoglobulin kappa constant |
chr13_-_23914998 | 1.06 |
ENSMUST00000021769.8
ENSMUST00000110407.2 |
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr1_+_150100093 | 1.04 |
ENSMUST00000035065.7
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2 |
chr1_-_172895048 | 1.03 |
ENSMUST00000027824.5
|
Apcs
|
serum amyloid P-component |
chr6_-_55175019 | 1.03 |
ENSMUST00000003569.5
|
Inmt
|
indolethylamine N-methyltransferase |
chr18_+_37504264 | 1.03 |
ENSMUST00000052179.6
|
Pcdhb20
|
protocadherin beta 20 |
chr11_+_117115195 | 1.02 |
ENSMUST00000103026.3
ENSMUST00000090433.5 |
Sec14l1
|
SEC14-like 1 (S. cerevisiae) |
chr1_-_162866502 | 1.02 |
ENSMUST00000046049.7
|
Fmo1
|
flavin containing monooxygenase 1 |
chr9_+_98864767 | 1.02 |
ENSMUST00000167951.1
|
2410012M07Rik
|
RIKEN cDNA 2410012M07 gene |
chr6_+_8259327 | 1.01 |
ENSMUST00000159378.1
|
Gm16039
|
predicted gene 16039 |
chr18_+_37447641 | 1.01 |
ENSMUST00000052387.3
|
Pcdhb14
|
protocadherin beta 14 |
chr2_+_43555321 | 1.00 |
ENSMUST00000028223.2
|
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr16_+_75592844 | 1.00 |
ENSMUST00000114249.1
ENSMUST00000046378.7 ENSMUST00000114253.1 |
Rbm11
|
RNA binding motif protein 11 |
chr5_-_131616599 | 1.00 |
ENSMUST00000161804.1
|
Auts2
|
autism susceptibility candidate 2 |
chr6_+_34780836 | 0.99 |
ENSMUST00000115012.1
ENSMUST00000115014.1 ENSMUST00000115009.1 |
Agbl3
|
ATP/GTP binding protein-like 3 |
chr5_-_131538687 | 0.99 |
ENSMUST00000161374.1
|
Auts2
|
autism susceptibility candidate 2 |
chr11_+_117115133 | 0.99 |
ENSMUST00000021177.8
|
Sec14l1
|
SEC14-like 1 (S. cerevisiae) |
chr3_-_63964659 | 0.99 |
ENSMUST00000161659.1
|
Slc33a1
|
solute carrier family 33 (acetyl-CoA transporter), member 1 |
chr11_-_58534825 | 0.99 |
ENSMUST00000170009.1
|
Olfr330
|
olfactory receptor 330 |
chr7_-_19166119 | 0.98 |
ENSMUST00000094790.3
|
Gipr
|
gastric inhibitory polypeptide receptor |
chrX_+_164506320 | 0.97 |
ENSMUST00000033756.2
|
Asb9
|
ankyrin repeat and SOCS box-containing 9 |
chr1_-_130729249 | 0.96 |
ENSMUST00000171479.1
|
Pfkfb2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
chr7_-_30856178 | 0.96 |
ENSMUST00000094583.1
|
Ffar3
|
free fatty acid receptor 3 |
chr2_-_125782834 | 0.95 |
ENSMUST00000053699.6
|
Secisbp2l
|
SECIS binding protein 2-like |
chr1_+_88166004 | 0.95 |
ENSMUST00000097659.4
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr6_-_129237948 | 0.95 |
ENSMUST00000181238.1
ENSMUST00000180379.1 |
2310001H17Rik
|
RIKEN cDNA 2310001H17 gene |
chr12_+_112678803 | 0.95 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr6_-_13871459 | 0.95 |
ENSMUST00000155856.1
|
2610001J05Rik
|
RIKEN cDNA 2610001J05 gene |
chr4_+_135686282 | 0.95 |
ENSMUST00000074408.6
|
Ifnlr1
|
interferon lambda receptor 1 |
chr7_-_104353328 | 0.94 |
ENSMUST00000130139.1
ENSMUST00000059037.8 |
Trim12c
|
tripartite motif-containing 12C |
chrX_-_134751331 | 0.94 |
ENSMUST00000113194.1
ENSMUST00000052431.5 |
Armcx6
|
armadillo repeat containing, X-linked 6 |
chr6_-_115592571 | 0.94 |
ENSMUST00000112957.1
|
2510049J12Rik
|
RIKEN cDNA 2510049J12 gene |
chr1_-_13127163 | 0.94 |
ENSMUST00000047577.6
|
Prdm14
|
PR domain containing 14 |
chr8_+_70724064 | 0.93 |
ENSMUST00000034307.7
ENSMUST00000110095.2 |
Pde4c
|
phosphodiesterase 4C, cAMP specific |
chr10_+_112271123 | 0.93 |
ENSMUST00000092175.2
|
Kcnc2
|
potassium voltage gated channel, Shaw-related subfamily, member 2 |
chr11_-_29515017 | 0.92 |
ENSMUST00000133103.1
ENSMUST00000039900.3 |
Prorsd1
|
prolyl-tRNA synthetase domain containing 1 |
chr7_-_25539845 | 0.92 |
ENSMUST00000066503.7
ENSMUST00000064862.6 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr4_+_86575668 | 0.92 |
ENSMUST00000091064.6
|
Rraga
|
Ras-related GTP binding A |
chr1_+_125561010 | 0.91 |
ENSMUST00000027580.4
|
Slc35f5
|
solute carrier family 35, member F5 |
chrX_-_103623704 | 0.91 |
ENSMUST00000130063.1
ENSMUST00000125419.1 |
Ftx
|
Ftx transcript, Xist regulator (non-protein coding) |
chr4_-_42034726 | 0.90 |
ENSMUST00000084677.2
|
Gm21093
|
predicted gene, 21093 |
chr11_+_58580837 | 0.89 |
ENSMUST00000169428.2
|
Olfr325
|
olfactory receptor 325 |
chr4_+_63558748 | 0.89 |
ENSMUST00000077709.4
|
6330416G13Rik
|
RIKEN cDNA 6330416G13 gene |
chr2_+_174760781 | 0.89 |
ENSMUST00000140908.1
|
Edn3
|
endothelin 3 |
chr17_+_5799491 | 0.87 |
ENSMUST00000181484.1
|
3300005D01Rik
|
RIKEN cDNA 3300005D01 gene |
chr3_+_154762157 | 0.87 |
ENSMUST00000098496.3
|
BC007180
|
cDNA sequence BC007180 |
chr5_+_102724971 | 0.86 |
ENSMUST00000112853.1
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr7_+_78914216 | 0.86 |
ENSMUST00000120331.2
|
Isg20
|
interferon-stimulated protein |
chr17_+_37270214 | 0.85 |
ENSMUST00000038580.6
|
H2-M3
|
histocompatibility 2, M region locus 3 |
chr3_-_129332713 | 0.85 |
ENSMUST00000029658.7
|
Enpep
|
glutamyl aminopeptidase |
chr9_+_107975529 | 0.84 |
ENSMUST00000035216.4
|
Uba7
|
ubiquitin-like modifier activating enzyme 7 |
chr13_+_40917626 | 0.84 |
ENSMUST00000067778.6
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
chr10_+_119992916 | 0.83 |
ENSMUST00000105261.2
|
Grip1
|
glutamate receptor interacting protein 1 |
chr5_-_87424201 | 0.83 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr3_+_108186332 | 0.83 |
ENSMUST00000050909.6
ENSMUST00000106659.2 ENSMUST00000106656.1 ENSMUST00000106661.2 |
Amigo1
|
adhesion molecule with Ig like domain 1 |
chr10_-_117292863 | 0.82 |
ENSMUST00000092162.5
|
Lyz1
|
lysozyme 1 |
chr11_+_34314757 | 0.82 |
ENSMUST00000165963.1
ENSMUST00000093192.3 |
Fam196b
|
family with sequence similarity 196, member B |
chr3_-_144932523 | 0.82 |
ENSMUST00000098549.3
|
AI747448
|
expressed sequence AI747448 |
chr5_+_147269959 | 0.81 |
ENSMUST00000085591.5
|
Pdx1
|
pancreatic and duodenal homeobox 1 |
chr6_-_115838412 | 0.81 |
ENSMUST00000032468.5
ENSMUST00000184428.1 |
Efcab12
|
EF-hand calcium binding domain 12 |
chr6_+_56017489 | 0.81 |
ENSMUST00000052827.4
|
Ppp1r17
|
protein phosphatase 1, regulatory subunit 17 |
chr2_-_5063996 | 0.81 |
ENSMUST00000114996.1
|
Optn
|
optineurin |
chr7_+_43408187 | 0.81 |
ENSMUST00000005592.6
|
Siglecg
|
sialic acid binding Ig-like lectin G |
chr13_-_119408985 | 0.80 |
ENSMUST00000099149.3
ENSMUST00000069902.6 ENSMUST00000109204.1 |
Nnt
|
nicotinamide nucleotide transhydrogenase |
chr17_+_34914459 | 0.80 |
ENSMUST00000007249.8
|
Slc44a4
|
solute carrier family 44, member 4 |
chr2_-_75938407 | 0.80 |
ENSMUST00000099996.3
|
Ttc30b
|
tetratricopeptide repeat domain 30B |
chr19_-_60861390 | 0.80 |
ENSMUST00000135808.1
|
Sfxn4
|
sideroflexin 4 |
chr9_+_5298517 | 0.80 |
ENSMUST00000027015.5
|
Casp1
|
caspase 1 |
chr8_-_109579056 | 0.79 |
ENSMUST00000074898.6
|
Hp
|
haptoglobin |
chr4_-_34050038 | 0.79 |
ENSMUST00000084734.4
|
Spaca1
|
sperm acrosome associated 1 |
chr9_+_54538984 | 0.79 |
ENSMUST00000060242.5
ENSMUST00000118413.1 |
Sh2d7
|
SH2 domain containing 7 |
chr11_-_3931789 | 0.79 |
ENSMUST00000109992.1
ENSMUST00000109988.1 |
Tcn2
|
transcobalamin 2 |
chr9_-_50528641 | 0.79 |
ENSMUST00000034570.5
|
Pts
|
6-pyruvoyl-tetrahydropterin synthase |
chr3_+_89436699 | 0.78 |
ENSMUST00000038942.3
ENSMUST00000130858.1 |
Pbxip1
|
pre B cell leukemia transcription factor interacting protein 1 |
chr9_+_44326804 | 0.78 |
ENSMUST00000054708.3
|
Dpagt1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
chr18_+_37484955 | 0.77 |
ENSMUST00000053856.4
|
Pcdhb17
|
protocadherin beta 17 |
chr2_+_157279026 | 0.77 |
ENSMUST00000116380.2
|
Rpn2
|
ribophorin II |
chr3_-_130709419 | 0.77 |
ENSMUST00000043937.7
|
Ostc
|
oligosaccharyltransferase complex subunit |
chr18_+_37442517 | 0.76 |
ENSMUST00000056915.1
|
Pcdhb13
|
protocadherin beta 13 |
chr5_-_147894804 | 0.76 |
ENSMUST00000118527.1
ENSMUST00000031655.3 ENSMUST00000138244.1 |
Slc46a3
|
solute carrier family 46, member 3 |
chr19_-_34166037 | 0.76 |
ENSMUST00000025686.7
|
Ankrd22
|
ankyrin repeat domain 22 |
chr9_+_78289923 | 0.76 |
ENSMUST00000119823.1
ENSMUST00000121273.1 |
Gm10639
|
predicted gene 10639 |
chr2_+_43555342 | 0.76 |
ENSMUST00000112826.1
ENSMUST00000050511.6 |
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr13_-_49215978 | 0.75 |
ENSMUST00000048946.6
|
1110007C09Rik
|
RIKEN cDNA 1110007C09 gene |
chr2_-_69342600 | 0.75 |
ENSMUST00000102709.1
ENSMUST00000102710.3 ENSMUST00000180142.1 |
Abcb11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr1_-_139377041 | 0.74 |
ENSMUST00000059825.5
|
Crb1
|
crumbs homolog 1 (Drosophila) |
chr9_-_121495678 | 0.74 |
ENSMUST00000035120.4
|
Cck
|
cholecystokinin |
chr9_-_123717576 | 0.73 |
ENSMUST00000026274.7
|
Lztfl1
|
leucine zipper transcription factor-like 1 |
chr7_+_102774495 | 0.73 |
ENSMUST00000098217.2
|
Olfr561
|
olfactory receptor 561 |
chr2_+_157279065 | 0.73 |
ENSMUST00000029171.5
|
Rpn2
|
ribophorin II |
chr3_-_107986360 | 0.72 |
ENSMUST00000066530.6
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr8_+_116504973 | 0.72 |
ENSMUST00000078170.5
|
Dynlrb2
|
dynein light chain roadblock-type 2 |
chr17_+_85090647 | 0.72 |
ENSMUST00000095188.5
|
Camkmt
|
calmodulin-lysine N-methyltransferase |
chr19_-_5845471 | 0.72 |
ENSMUST00000174287.1
ENSMUST00000173672.1 |
Neat1
|
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
chr11_+_5520652 | 0.71 |
ENSMUST00000063084.9
|
Xbp1
|
X-box binding protein 1 |
chr13_+_74406387 | 0.71 |
ENSMUST00000090860.6
|
Gm10116
|
predicted pseudogene 10116 |
chr6_-_116716888 | 0.71 |
ENSMUST00000056623.6
|
Tmem72
|
transmembrane protein 72 |
chr7_-_35056467 | 0.71 |
ENSMUST00000130491.1
|
Cebpg
|
CCAAT/enhancer binding protein (C/EBP), gamma |
chr19_+_34640871 | 0.71 |
ENSMUST00000102824.3
|
Ifit1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr14_+_65971049 | 0.70 |
ENSMUST00000128539.1
|
Clu
|
clusterin |
chr10_+_62920630 | 0.70 |
ENSMUST00000044977.3
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chr6_+_135198034 | 0.70 |
ENSMUST00000130612.1
|
8430419L09Rik
|
RIKEN cDNA 8430419L09 gene |
chr5_+_90561102 | 0.70 |
ENSMUST00000094615.4
|
5830473C10Rik
|
RIKEN cDNA 5830473C10 gene |
chr3_+_92288566 | 0.70 |
ENSMUST00000090872.4
|
Sprr2a3
|
small proline-rich protein 2A3 |
chr18_+_37489465 | 0.70 |
ENSMUST00000055949.2
|
Pcdhb18
|
protocadherin beta 18 |
chr9_+_77917364 | 0.70 |
ENSMUST00000034904.7
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr4_-_45532470 | 0.69 |
ENSMUST00000147448.1
|
Shb
|
src homology 2 domain-containing transforming protein B |
chr2_-_10130638 | 0.69 |
ENSMUST00000042290.7
|
Itih2
|
inter-alpha trypsin inhibitor, heavy chain 2 |
chr10_-_24092320 | 0.69 |
ENSMUST00000092654.2
|
Taar8b
|
trace amine-associated receptor 8B |
chr13_-_48625571 | 0.69 |
ENSMUST00000035824.9
|
Ptpdc1
|
protein tyrosine phosphatase domain containing 1 |
chrX_+_56346390 | 0.69 |
ENSMUST00000101560.3
|
Zfp449
|
zinc finger protein 449 |
chr10_-_53699343 | 0.68 |
ENSMUST00000163761.1
|
Fam184a
|
family with sequence similarity 184, member A |
chrX_-_101059655 | 0.68 |
ENSMUST00000113718.1
ENSMUST00000113716.2 |
Tex11
|
testis expressed gene 11 |
chr3_-_96263311 | 0.68 |
ENSMUST00000171473.1
|
Hist2h4
|
histone cluster 2, H4 |
chr6_+_122553799 | 0.68 |
ENSMUST00000043301.7
|
Aicda
|
activation-induced cytidine deaminase |
chr14_+_32991430 | 0.68 |
ENSMUST00000123822.1
ENSMUST00000120951.1 |
Lrrc18
|
leucine rich repeat containing 18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.4 | 5.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 6.8 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.0 | 3.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 3.6 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.6 | 1.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.6 | 1.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 2.1 | GO:1990743 | protein sialylation(GO:1990743) |
0.5 | 3.0 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.4 | 1.8 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.4 | 5.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 1.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 3.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 1.9 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.4 | 2.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 2.8 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 4.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 1.3 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.3 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 1.3 | GO:0006311 | meiotic gene conversion(GO:0006311) male meiosis chromosome segregation(GO:0007060) gene conversion(GO:0035822) |
0.3 | 1.0 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.3 | 0.9 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 1.8 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 1.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.3 | 1.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.8 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.3 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.8 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.3 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.7 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.2 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 2.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.6 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.2 | 0.6 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.6 | GO:0090265 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.2 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 1.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.5 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.2 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.3 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 1.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.2 | 0.8 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.5 | GO:1901079 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) positive regulation of relaxation of muscle(GO:1901079) |
0.2 | 0.5 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.4 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.1 | 0.4 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.9 | GO:0014826 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.1 | 1.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.7 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.1 | 1.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 1.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 1.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.7 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.1 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.7 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 1.3 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 1.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.3 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.5 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 1.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.3 | GO:2000065 | neural fold elevation formation(GO:0021502) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.5 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 0.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 9.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 3.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.0 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) |
0.1 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 1.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.3 | GO:0072338 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.2 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 0.7 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.2 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.1 | 0.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.2 | GO:0070340 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 1.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 1.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.6 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 1.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.0 | 0.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 1.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 1.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 1.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.9 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.0 | 3.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.9 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 1.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 3.2 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 1.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0015676 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.0 | 0.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.8 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 1.0 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.0 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.0 | 1.6 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.4 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.0 | 0.2 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.9 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.3 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.0 | 0.2 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.0 | 0.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 1.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.4 | GO:0090662 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.9 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.0 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.0 | 0.1 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.0 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.0 | 0.0 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:1902956 | negative regulation of oxidative phosphorylation(GO:0090324) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 1.2 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 1.7 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 1.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.0 | GO:0070429 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) tolerance induction to lipopolysaccharide(GO:0072573) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.3 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 2.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 5.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.3 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 1.4 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.7 | GO:0097447 | dendritic tree(GO:0097447) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 3.0 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 2.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.0 | GO:0048500 | signal recognition particle(GO:0048500) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 2.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 1.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 1.4 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 4.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 4.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 2.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 1.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 1.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 3.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.5 | 3.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 1.8 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.4 | 1.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 2.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.4 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 1.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.4 | 3.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 8.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 1.3 | GO:0070976 | TIR domain binding(GO:0070976) |
0.3 | 11.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 2.5 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.4 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 2.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 1.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 1.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 1.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 9.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 2.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) palmitoyl-CoA oxidase activity(GO:0016401) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 2.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 3.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 5.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 0.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 1.5 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.1 | 0.3 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.9 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.2 | GO:0036004 | GAF domain binding(GO:0036004) |
0.1 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 2.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) 7S RNA binding(GO:0008312) |
0.0 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.4 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 2.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 1.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 1.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 1.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 1.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 1.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 1.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 1.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 2.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 7.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 5.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 3.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 2.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 1.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 2.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 2.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |